More information
Living with dementia
Find dementia activities near you
Staying independent with dementia
Looking after someone with dementia
Dementia and your relationships
Communicating with people with dementia
Coping with dementia behaviour changes
Care and support
Dementia, social services, and the NHS
Managing legal affairs for someone with dementia
General Information and Support
- Lewy Body Dementia Association
- The Lewy Body Dementia Association provides general information about the disease, support information for caregivers, a newsletter, and lots of links.
- Lewy Body Society
- The Lewy Body Dementia Society is a charitable organization in the United Kingdom with the mission of raising awareness of LBD throughout Europe.
- Lewy Body Foundation
- The Lewy Body Dementia Foundation is an Australian group that proposes to fund research on LBD and Parkinson’s disease.
Articles About Lewy Body Disease
- Fact Sheet: Dementia with Lewy Bodies
- This fact sheet from the Family Caregiver Alliance describes Lewy body disease and its symptoms.
- Dementia with Lewy Bodies
- Written by Howard A. Crystal, M.D., in 2001 (but updated more recently), this in-depth article describes Lewy body disease and the kinds of medication used to treat it.
- Technical Articles/Current Research
- A great source of information is the National Library of Medicine. Enter “Lewy body disease” into the search field to find abstracts of published research articles.
E-Mail Message Groups
- LBD Caring Spouses
- Somewhat active Yahoo message group for caregivers and spouses.
Message Boards
- Lewy Body Dementia Association Forum
- The forum of the Lewy Body Dementia Association.
- Alzheimer’s Association’s Online Community
- The Alzheimer’s Association has several message boards, including one for caregivers and another for getting advice from care consultants (not specific to Lewy body disease).
- Alzheimer’s Disease and Dementia Forum
- This NeuroTalk Communities message board about Alzheimer’s disease and other dementias is hosted by Psych Central, a mental health network.
Coping
- Find Your Chapter
- Through the Alzheimer’s Association, you can locate a local chapter and find out about support groups in your area.
- Family Caregivers: Coping
- The Alzheimer’s Association has information about coping.
- Caregivers Services
- The Lewy Body Dementia Association has information for caregivers, along with information about support groups for LBD.
Links to Other LBD Resources
Lewy Body Dementia: Information for Patients, Families, and Professionals
A 40-page booklet that helps people with LBD, their families, and professionals learn more about the disease and resources for coping. Developed in collaboration with LBDA, published by the National Institute of Health.
Mind, Mood & Memory (pdf)
A 100 page booklet from the National Parkinson’s Foundations on Lewy body dementias.
Clinical Dementia Rating Scale
Test widely used by doctors, covering aspects of LBD and Alzheimer’s. Lewy Body Dementia NINDS Information Page. National Institute of Neurological Disorders and Stroke.
Dementia with Lewy Bodies
From the Family Caregiver Alliance, National Center on Caregiving.
Lewy Body Society
A British LBD charity dedicated to raising awareness of dementia with Lewy bodies (DLB) in the general public and educating medical professionals and decision makers about all aspects of the disease, and to support research.
The Movement Disorder Society
An international society of medical professionals interested in movement disorders.
National Institute of Neurological Disorders and Stroke, www.ninds.nih.gov
Alzheimer’s Association End-of-Life Decisions Brochure
- This 694K PDF document includes information about feeding tubes and the position of the Alzheimer’s Association.
- The Cost of Dying: Simple act of feeding poses painful choices
- Informative article published by MercuryNews.com.
Genetics Home Reference: Dementia with Lewy Bodies
Dementia with Lewy bodies is a nervous system disorder characterized by a decline in intellectual function (dementia), a group of movement problems known as parkinsonism, visual hallucinations, sudden changes (fluctuations) in behavior and intellectual ability, and acting out dreams while asleep (REM sleep behavior disorder).
This condition typically affects older adults, most often developing between ages 50 and 85. The life expectancy of individuals with dementia with Lewy bodies varies; people typically survive about 5 to 7 years after they are diagnosed.
REM sleep behavior disorder is usually the first sign of dementia with Lewy bodies. It can occur years before other symptoms appear.
Individuals with REM sleep behavior disorder act out their dreams, talking and moving in their sleep. This behavior becomes less pronounced as dementia with Lewy bodies worsens and additional features develop.
Dementia is often the second major feature to develop in dementia with Lewy bodies. This intellectual decline often leads to impaired ability to perform visual-spatial tasks such as puzzles.
Affected individuals may also have poor problem-solving skills (executive functioning), speech difficulties, and reduced inhibitions. Problems with memory typically do not occur until later.
In people with dementia with Lewy bodies, visual hallucinations typically involve people or animals. Fluctuations in behavior and intellectual ability include sudden changes in attention, thought processes, and mood.
Affected individuals might have inconsistent behaviors, unintelligible speech, and brief episodes of altered consciousness that may appear as staring spells.
Parkinsonism is usually the last major feature to develop in people with dementia with Lewy bodies.
In affected individuals, the movement problems typically include tremors, rigidity, unusually slow movement (bradykinesia), and impaired balance and coordination (postural instability). Affected individuals often require walking aids or wheelchair assistance.
Individuals with dementia with Lewy bodies may also experience a sharp drop in blood pressure upon standing (orthostatic hypotension), fainting episodes (syncope), difficulty controlling the flow of urine (incontinence), or constipation.
-
Is Parkinson’s Disease Dementia Different than Dementia with Lewy Bodies?
-
How Is Lewy Body Dementia Different from Alzheimer’s Disease?
-
Does Lewy Body Dementia Have Stages? How Does It Progress?
-
Strategies for Responding to Hallucinations in Lewy Body Dementia
-
Capgras Syndrome in Lewy Body Dementia: What Is It and How Should You Respond?
- Rare Dementia Support service.
- Rare Dementia Support runs specialist support services for individuals living with, or affected by, one of five rare dementia diagnoses:
frontotemporal dementia (FTD)
posterior cortical atrophy (PCA)
primary progressive aphasia (PPA)
familial Alzheimer’s disease (FAD)
familial frontotemporal dementia (fFTD) -
Multi-infarct dementia: factsheet from NINDS, the National Institute of Neurological Disorders and Stroke (US site)
Dementia with Lewy Bodies: factsheet from NINDS, the National Institute of Neurological Disorders and Stroke (US site)
Lewy body dementia: information from NHS Choices
Dementia: factsheet from NINDS, the National Institute of Neurological Disorders and Stroke (US site)
Dementia: information from Patient UK website
Dementia: information from NHS Choices
National Institute on Aging: US site from National Institute of Health. Aimed at older adults
Posterior cortical atrophy: information from the Alzheimer’s Disease Society
The London Centre for Dementia Care
This organisation was established in 1998 and is hosted by University College London.The Carers Trust
If you are looking after someone with dementia, it’s important that you know how to get help and support for yourself as well. This is a good place to start looking for information and advice on how to get help and support, and even a break from caring.The Lewy Body Society
The Lewy Body Society was founded in 2006 in order to raise awareness and educate the public, the medical profession and those in health-care decision-making positions about Dementia with Lewy bodies.Pick’s Disease Support group
Set up by carers of people with Pick’s disease and other focal and unusual dementias. The group produces newsletters and gives information and advice.The Progressive Supranuclear Palsy (PSP Europe) Association
Organises local support groups where there are enough patients.Western Alzheimer Foundation (Irish site)
Promotes awareness through consultation and support group meetings. Gives practical help with a home support service.Alzheimer’s Association (US site)
This USA based charity gives information and assistance on issues related to Alzheimer’s disease. Website includes links to regional “chapters” for the USA. Funds research and has an extensive information service.Alzheimer Society of Canada
National society web page with the latest information on Alzheimer disease, care, research and Society programs to help Canadians affected by Alzheimer disease. Links to local and international organisations.Created Out of Mind
This interdisciplinary team of scientists, visual artists, musicians, broadcasters, clinicians and carers aims to explore, challenge and shape perceptions and understanding of dementias through science and the creative arts, exploring what dementia means, challenging traditional definitions and common misconceptions, and unlocking what can be learnt about art, consciousness and the brain from the experiences of people living with different dementias.Their short animated film about dementia ‘Do I see what you see?’ recreates the experiences of people living with Posterior Cortical Atrophy (PCA), a rare form of dementia which affects the visual areas of the brain, in a series of striking animations. The film was developed in partnership with Alzheimer’s Society and is supported by Wellcome.
Personal Testimony
Lewy Body Journal
- Who Mother Was
- First Hints of Trouble
- The Signs Become More Pronounced
- Back to the Neurologist
- Aricept and Mother’s Quick Decline
- Columbia Presbyterian Hospital
- Dr. Jekyll and Mrs. Hyde
- Living Arrangements and Daycare
- We Need Aides
- Things Get a Bit Worse
- The Wheelchair Ramp
- “I Want to Die”
- Hygiene and Dental Care
- Slow Decline Continues
- Living Will
- Coping
- Future Concerns
- The Wound Doctor (April 2003)
- Various Problems (August 2003)
- Stasis (May 2004)
- Little Change (May 2005)
- The New Doctor (March 2006)
- Final Days (May 2006)
- In Memoriam (May 2006)
- Lewy Body Journal Links
-
Dementia with Lewy Bodies
Dementia with Lewy Bodies is a common form of dementia. Free medical information and advise about Dementia with Lewy Bodies.More: Evidence Summaries -
Lewy body dementia: information for patients, families, and professionals [PDF]
This booklet is meant to help people with lewy body dementia, their families, and professionals learn more about the disease and resources for coping.– More: Evidence Summaries -
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis
patient and caregiver views of pharmacological management strategies for Lewy body dementia. METHOD: Studies…– More: Systematic Reviews -
Intepirdine for dementia with Lewy bodies
Intepirdine is a new drug to treat patients with dementia with Lewy bodies. Lewy bodies are deposits of an abnormal protein inside brain cells. These deposits build up in areas of the brain…More: Horizon Scanning -
Memantine: a new hope for treatment of Lewy body-related dementias?
Lewy body-related dementias—Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB)—constitute the second most frequent cause of primary degenerative dementias. Although there are…– More: Evidence Summaries -
The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review
studies are essential for understanding the societal burden of dementia with Lewy bodies (DLB). METHODS: The…– More: Systematic Reviews -
Is donepezil effective for treatment of Lewy Body dementia?
Is donepezil effective for treatment of Lewy Body dementia? Record typeUncertainties identified from clinicians’…More: Evidence Uncertainties -
Dementia with Lewy bodies
Two main types of dementia affect people with Parkinson’s – they’re called Parkinson’s dementia and dementia with Lewy bodies. Communication;Dementia;Drug;Information and communications…– More: Information for the Public -
Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis
BACKGROUND: The diagnosis of dementia with Lewy bodies (DLB) is based on diagnostic clinical criteria, which…– More: Systematic Reviews -
What is dementia with Lewy bodies? [PDF]
Information in this booklet is for anyone who wants to know more about dementia with Lewy bodies (DLB). This includes people living with DLB, their carers, families and friends. The booklet aims to…– More: Information for the Public -
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease
cholinesterase inhibitors in both Parkinson’s disease with dementia (PDD) and dementia with Lewy…More: Systematic Reviews -
Dementia with Lewy bodies – NHS
Find out about a type of dementia called dementia with Lewy bodies, including what the symptoms are, how it’s treated and what the outlook is. -
Systematic review of the efficacy of non-pharmacological interventions in people with Lewy body dementia
BACKGROUND: Pharmacological interventions for Lewy body dementia (LBD), especially for its non-cognitive…– More: Systematic Reviews -
123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewybodies and other dementias
123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies (DLB) and other…– More: Systematic Reviews -
Cholinesterase inhibitors for dementia with Lewy bodies
Background Dementia with Lewy bodies (DLB) was first described in 1983, and clinical diagnostic criteria were…More: Systematic Reviews -
Lewy Body Dementia
The diagnosis of LBD is not always straightforward and it can take several consultations before it is recognised correctly. -
Memantine in patients with Parkinson’s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
Background Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) are common forms of dementia that substantially affect quality of life. Currently, the only treatment licensed…– More: Evidence Summaries -
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Breitve MH, Chwiszczuk LJ, Hynninen MJ et al. (2014) A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease. 6(5-8),2014.53, 2014.:6 The link…– More: Systematic Reviews -
Exercise for Individuals with Lewy Body Dementia: A Systematic Review
BACKGROUND: Individuals with Lewy body Dementia (LBD), which encompasses both Parkinson disease…– More: Systematic Reviews -
Acute tryptophan depletion and Lewy body dementias
on the severe cholinergic loss evident in dementia with Lewy bodies (DLB) and Parkinson’s disease and…– More: Primary Research -
Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies
Background Dementia with Lewy bodies (DLB) is a common cause of neurodegenerative dementia of…More: Systematic Reviews -
What is dementia with Lewy bodies
push({“categoryLevel1”:”About dementia“,”categoryLevel2”:”Types of dementia“,”categoryLevel3″:”Dementia with… -
An introduction to dementia with Lewy bodies
An introduction to dementia with Lewy bodies – Social Care Online– More: Primary Research -
Dementia with Lewy bodies: Understanding your diagnosis
window.dataLayer || []; window.dataLayer.push({“categoryLevel1″:”Dementia with Lewy bodies: Understanding your… -
Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies
Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published…More: Systematic Reviews -
Parkinson’s/Lewy body dementia: a carer’s perspective
Parkinson’s/Lewy body dementia: a carer’s perspective – Social Care Online– More: Case Studies -
The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementiawith Lewy bodies: a systematic review and meta-analysis
diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies: a systematic…More: Systematic Reviews -
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementiawith Lewy bodies: systematic review with meta-analysis and trial sequential analysis
impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies:…More: Systematic Reviews -
Systemic inflammation in Dementia with Lewy Bodies and Alzheimer’s Disease
Dementia with Lewy Bodies accounts for up to one quarter of all cases of dementia in the elderly….More: Ongoing Trials -
The first confirmed case of Down syndrome with dementia with Lewy bodies
The first confirmed case of Down syndrome with dementia with Lewy bodies – Social Care Online– More: Primary Research -
In people with Parkinson’s disease dementia (PDD), Parkinson’s disease cognitive impairment (CIND‐PD), or dementia with Lewy bodies (DLB), what are the effects of cholinesterase inhibitors?
people with Parkinson’s disease dementia (PDD), Parkinson’s disease cognitive impairment (CIND‐PD), or dementia with…More: Systematic Reviews -
Stress and burden among caregivers of patients with Lewy Body Dementia
Stress and burden among caregivers of patients with Lewy Body Dementia – Social Care Online– More: Primary Research -
The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies
of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies – Social Care Online– More: Primary Research -
Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewybodies
Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies – Social Care Online– More: Primary Research -
Improving the diagnosis and management of neurodegenerative dementia of Lewy body type in the NHS (DIAMOND-Lewy): Work package 1
focuses on Lewy Body Dementia (LBD) which includes two related disorders: Dementia with…More: Ongoing Trials -
Depressive symptoms are associated with daytime sleepiness and subjective sleep quality in dementia with Lewy bodies
associated with daytime sleepiness and subjective sleep quality in dementia with Lewy bodies – Social Care…– More: Primary Research -
123l-MlBG in Dementia with Lewy bodies as a marker for sympathetic denervation (Pilot and Feasibility Study)
impairment of cardiac nerve integrity (denervation) in patients with Dementia with Lewy Bodies (DLB). DLB is a…More: Ongoing Trials -
Increased plasma donepezil concentration improves cognitive function in patients with dementia with Lewy bodies: an exploratory pharmacokinetic/pharmacodynamic analysis in a phase 3 randomized controlled trial
neuropsychiatric symptoms without compromising safety in patients with dementia with Lewy bodies(DLB)….– More: Primary Research -
What are the most effective ways, pharmacological and non-pharmacological, of treating and caring for different/rarer types of dementia e.g. vascular dementia, early onset, fronto-temporal, Lewy Body dementia, Picks disease?
caring for different/rarer types of dementia e.g. vascular dementia, early onset, fronto-temporal, Lewy…More: Evidence Uncertainties -
Biomedical Research Unit: Acute and Chronic effects of Transcranial Direct Current stimulation in Lewy body dementia patients: a pilot study
In Lewy body dementias (LBD) complex, recurrent visual hallucinations (VH) and problems with how one perceives…
-
Improving the diagnosis and management of neurodegenerative dementia of Lewy body type in the NHS. Work Package 5A and 5B: A pilot cluster randomised study of the management toolkit in the NHS secondary care services
Dementia with Lewy Bodies (DLB) and Parkinson’s Disease Dementia (PDD) together are known as…More: Ongoing Trials -
Clinical practice with anti-dementia drugs: a revised (third) consensus statement from the British Association for Psychopharmacology [PDF]
The British Association for Psychopharmacology coordinated a meeting of experts to review and revise its previous 2011 guidelines for clinical practice with anti-dementia drugs. Levels of evidence…– More: Guidance -
Structural and Functional Neuroimaging of Visual Hallucinations in Lewy BodyDisease: A Systematic Literature Review
Patients with Lewy body disease (LBD) frequently experience visual hallucinations (VH), well-formed images perceived…– More: Systematic Reviews -
The diagnostic utility of EEG in early-onset dementia: a systematic review of the literature with narrative analysis
The diagnostic utility of EEG in early-onset dementia: a systematic review of the literature with narrative analysisMore: Systematic Reviews -
Pain Experience in Dementia Subtypes: A Systematic Review
pain in dementia has increased considerably. Still, little attention has been paid to the influence of the neuropathology of different…– More: Systematic Reviews -
7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature
subcortical nuclei. It may reveal new information about neurodegenerative dementias, although challenges may include increased artefact…– More: Systematic Reviews -
All about dementia [PDF]
A useful guide for people living with dementia, their carers, friends and families. it gives an introduction to Alzheimer’s disease, dementia with Lewy bodies, vascular dementia and frontotemporal…– More: Information for the Public -
Sleep and Neurodegeneration: a critical appraisal
Alzheimer’s disease and synucleinopathies (i.e., Parkinson’s disease, dementia with Lewy bodies, multiple…– More: Systematic Reviews -
Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations
possible dementia. Objectives To determine the diagnostic accuracy of the Mini-Mental State Examination (MMSE) at various cut points for…More: Systematic Reviews -
Treatment for dementia [PDF]
This booklet gives an overview of the treatments currently available for dementia. It includes information about the drugs available to treat Alzheimer’s disease, including how they work and…– More: Information for the Public -
Memory Loss and Dementia
Many people become forgetful as they become older. This is common and is often not due to dementia. -
Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry
Cross-sectional Swedish study (n=29,630) found that diabetes was associated with lower age at dementia diagnosis (OR 0.97, 99% CI 0.97 to 0.98). Dementia with Lewy bodies, Parkinson’s disease…– More: Primary Research -
Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI)
Background Dementia is a progressive global cognitive impairment syndrome. In 2010, more than 35 million people worldwide were…More: Systematic Reviews -
Dementia: assessment, management and support for people living with dementia and their carers : guidance (NG97)
Evidence-based recommendations on diagnosing and managing dementia (including Alzheimer’s disease)– More: Guidance -
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F-fluorodeoxyglucosepositron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
BACKGROUND AND PURPOSE: Recommendations for using fluorodeoxyglucose positron emission tomography (FDG-PET) to support the diagnosis of dementing neurodegenerative disorders are sparse and…– More: Guidance -
Dementia and people with intellectual disabilities: guidance on the assessment, diagnosis, interventions and support of people with intellectual disabilities who develop dementia [PDF]
The main purpose of this report is to enable those working in clinical and social care services to improve the quality of life of people with learning disabilities who develop dementia, by…– More: Guidance -
Dementia | Treatment summary
Source: British National Formulary – BNF – Description of condition Dementia is a progressive and largely irreversible clinical syndrome that is characterised by a widespread… -
Dementia
Source: Clinical Knowledge Summaries –
Dementia is a clinical syndrome of deterioration in mental function which interferes with activities of daily living (ADLs).– More: Guidance -
Risperidone 0.5mg, 1mg, 2mg, 3mg, 4mg and 6mg Film-Coated Tablets – PL 08137/0160-5 [PDF]
This is just the first MHRA Public Assessment Report from your search. See alltreatment (up to 6 weeks) of long-term aggression in people with Alzheimer’s dementia, who harm themselves or others, where other… -
DaTSCAN | European Medicines Agency
disease;dementia (loss of intellectual function). DaTSCAN is used to help distinguish between a type of dementia known as… -
Post-mortem examination in dementia
Neuropathology autopsy practice: Post-mortem examination in dementia September 2014 Authors: Professor James Lowe, UniversityMore: Policy and Strategy -
NICE Bites; Dementia [PDF]
guidance NICE Bites October 2018: No 111 Dementia Assessment, management and support for people living with dementia and… -
ACR appropriateness criteria: Dementia and Movement Disorders
Appropriateness Criteriar 1 Dementia and Movement Disorders American College of Radiology ACR Appropriateness Criteriar Clinical…More: Guidance -
New Drugs for Dementia [PDF]
A POSTnote outlining the challenges in developing new drugs to treat dementia, and an overview of UK and international research activities to accelerate progress.– More: Evidence Summaries -
ASENAPINE | Drug
Source: British National Formulary – BNF – Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for ASENAPINE. -
SNM practice guideline for dopamine transporter imaging with 123 I-Ioflupane SPECT 1.0 [PDF]
The purpose of this information is to assist health care professionals in performing, interpreting, and reporting the results of DaT imaging with 123 I-ioflupane SPECT.– More: Guidance -
Appropriate use criteria for amyloid PET [PDF]
To provide guidance for physicians, individuals and families affected by Alzheimer’s, and the public, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer’s Association…– More: Guidance -
The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review
incidence studies are essential for understanding the burden of frontotemporal dementia (FTD). METHODS: The MEDLINE and EMBASE databases…– More: Systematic Reviews -
PALIPERIDONE | Drug
Source: British National Formulary – BNF – Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for PALIPERIDONE. -
Parkinson’s disease
Source: Clinical Knowledge Summaries –
Parkinson’s disease is a chronic, progressive neurodegenerative condition resulting from the loss of the dopamine-containing cells of the substantia nigra.– More: Guidance -
ARCHIVED SEPT 2015. Antipsychotic Medicines Audit and Reduction Tool Vs1[DOC]
Appendix 2: Dementia read codes, anti-dementia drugs & antipsychotics Dementia Read Codes… -
Intepirdine
listed for this indication in the company pipeline. Development in Lewy body dementia continues [1]. ·More: Horizon Scanning -
Cognitive impairment. Part one: symptoms to diagnosis. Clinical practice guideline. [PDF]
Mild cognitive impairment (MCI) – also referred to as mild neurocognitive disorder – is a term for modest acquired cognitive deficits (usually with memory) that is more than expected for the…– More: Guidance -
Gray matter atrophy in Parkinson’s disease with dementia: evidence from meta-analysis of voxel-based morphometry studies
Pan PL, Shi HC, Zhong JG et al (2013) Gray matter atrophy in Parkinson’s disease with dementia : evidence from meta-analysis of voxel-based morphometry studies. Neurological…– More: Systematic Reviews -
Charles Bonnet Syndrome
Charles Bonnet Syndrome common amongst people who have lost their sight. Complex hallucinations are synonymous with Charles Bonnet SyndromeMore: Evidence Summaries -
RISPERIDONE | Drug
Source: British National Formulary – BNF – Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for RISPERIDONE. -
ARCHIVED SEPT 2015. Antipsychotic Medicines Audit and Reduction Tool Vs1[DOC]
Guidelines for discontinuation and reduction of antipsychotics in dementia patients in the community General Principles These Guidelines… -
The relationship of specific items on the Neuropsychiatric Inventory to caregiver burden in dementia: a systematic review
OBJECTIVE: Neuropsychiatric symptoms (NPSs) are common in dementia, and they have been identified as important care-recipient variables…– More: Systematic Reviews -
Delirium
Source: Clinical Knowledge Summaries
Delirium (sometimes called ‘acute confusional state’) is an acute, fluctuating syndrome of inattention, impaired level of consciousness, and disturbed cognition.– More: Guidance -
A systematic review and meta-analysis examining pneumonia-associated mortality in dementia
Foley NC, Affoo RH, Martin RE. (2014) A Systematic Review and Meta-Analysis Examining Pneumonia-Associated Mortality in Dementia. Dementia and Geriatric Cognitive Disorders 39 :52-67. [Epub ahead…
Lewy Body Dementia UK 